Aurubis AG (LON:0K7F)
112.00
-0.70 (-0.62%)
At close: Nov 5, 2025
Aurubis AG Revenue
Aurubis AG had revenue of 4.62B EUR in the quarter ending June 30, 2025, a decrease of -1.89%. This brings the company's revenue in the last twelve months to 18.03B, up 5.45% year-over-year. In the fiscal year ending September 30, 2024, Aurubis AG had annual revenue of 17.18B with 0.44% growth.
Revenue (ttm)
18.03B EUR
Revenue Growth
+5.45%
P/S Ratio
0.28
Revenue / Employee
2.58M EUR
Employees
6,979
Market Cap
4.30B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 17.18B | 74.62M | 0.44% |
| Sep 30, 2023 | 17.11B | -1.44B | -7.76% |
| Sep 30, 2022 | 18.55B | 2.22B | 13.57% |
| Sep 30, 2021 | 16.33B | 3.88B | 31.17% |
| Sep 30, 2020 | 12.45B | 534.01M | 4.48% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 140.08B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |